The therapeutic potential of the ketogenic diet in selected neurodegenerative diseases and psychiatric disorders
DOI:
https://doi.org/10.12775/QS.2026.94.72728Keywords
ketogenic diet, β-hydroxybutyrate, metabolic psychiatry, Alzheimer's disease, bipolar disorder, neuroinflammation, neuroplasticityAbstract
Background: Pharmacoresistance in central nervous system (CNS) pathologies remains a major clinical challenge. The ketogenic diet (KD) is emerging as a potential multimodal metabolic therapy. Ketone bodies appear to remodel neuronal bioenergetics and modulate neurotransmission, laying the groundwork for the developing field of metabolic psychiatry.
Aim & Methods: This narrative review (2010–2026) evaluates the neurobiochemical mechanisms of ketone bodies and the potential of the KD as an adjuvant intervention in selected neurodegenerative (Alzheimer's, Parkinson's) and psychiatric (bipolar disorder, schizophrenia, treatment-resistant depression) conditions.
Results: Evidence suggests that β-hydroxybutyrate (BHB) crosses the blood-brain barrier via monocarboxylate transporters to fuel the tricarboxylic acid cycle, potentially bypassing the neuronal insulin resistance—often termed type 3 diabetes—implicated in Alzheimer's disease. At the cellular level, BHB may exert neuroprotective effects by inhibiting the NLRP3 inflammasome, which appears to reduce the release of proinflammatory cytokines. Furthermore, ketosis is associated with amino acid pathway remodeling; it may stimulate glutamic acid decarboxylase (GAD) activity, potentially shifting the neurotransmitter balance toward inhibitory GABAergic transmission relevant to mood stabilization. Additionally, BHB acts as an endogenous histone deacetylase (HDAC) inhibitor, which might upregulate brain-derived neurotrophic factor (BDNF) expression and facilitate neurogenesis.
Conclusions: The KD is a promising neurometabolic intervention that may target underlying CNS pathomechanisms through mitochondrial optimization, anti-inflammatory effects, and epigenetic modifications. Despite encouraging initial reports, widespread implementation requires strict metabolic monitoring. Large-cohort randomized trials remain necessary before integrating ketogenic protocols into standard neuro-psychiatric treatment algorithms.
References
[1] Mikołajec, P., Jolanta Mędyk, Michał Rogulski , Yauheniya Patarocha, Aleksandra Ślusarska , Paulina Błasiak , … Barbara Bilecka . (2025). The Effects of the Ketogenic Diet on Disorders of Central Nervous System. Journal of Education, Health and Sport, 78, 57586. https://doi.org/10.12775/JEHS.2025.78.57586
[2] Mentzelou, M., Dakanalis, A., Vasios, G. K., Gialeli, M., Papadopoulou, S. K., & Giaginis, C. (2023). The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice. Nutrients, 15(10), 2270. https://doi.org/10.3390/nu15102270
[3] Pawłowska, M., Kruszka, J., Porzych, M., Garbarek, J., & Nuszkiewicz, J. (2025). Ketogenic Metabolism in Neurodegenerative Diseases: Mechanisms of Action and Therapeutic Potential. Metabolites, 15(8), 508. https://doi.org/10.3390/metabo15080508
[4] Veech R. L. (2004). The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins, leukotrienes, and essential fatty acids, 70(3), 309–319. https://doi.org/10.1016/j.plefa.2003.09.007
[5] Sampaio L. P. (2016). Ketogenic diet for epilepsy treatment. Arquivos de neuro-psiquiatria, 74(10), 842–848. https://doi.org/10.1590/0004-282X20160116
[6] Domańska, N., Bojarska, M., Bogucka, J., Brzyska, A., Kosowska, M., & Piecewicz-Szczęsna, H. (2025). Beyond the seizures: Ketogenic Diets in the battle against drug-resistant epilepsy. Journal of Education, Health and Sport, 77, 56870. https://doi.org/10.12775/JEHS.2025.77.56870
[7] Kossoff, E. H., Zupec-Kania, B. A., Auvin, S., Ballaban-Gil, K. R., Christina Bergqvist, A. G., Blackford, R., Buchhalter, J. R., Caraballo, R. H., Cross, J. H., Dahlin, M. G., Donner, E. J., Guzel, O., Jehle, R. S., Klepper, J., Kang, H. C., Lambrechts, D. A., Liu, Y. M. C., Nathan, J. K., Nordli, D. R., Jr, Pfeifer, H. H., … Practice Committee of the Child Neurology Society (2018). Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia open, 3(2), 175–192. https://doi.org/10.1002/epi4.12225
[8] D'Andrea Meira, I., Romão, T. T., Pires do Prado, H. J., Krüger, L. T., Pires, M. E. P., & da Conceição, P. O. (2019). Ketogenic Diet and Epilepsy: What We Know So Far. Frontiers in neuroscience, 13, 5. https://doi.org/10.3389/fnins.2019.00005
[9] Cuber, I., Aghadi, A., Białowąs, E., Dybała, E., Mazurek, M., & Górna, M. (2023). Ketogenic diet - a literature review. Journal of Education, Health and Sport, 13(4), 132–141. https://doi.org/10.12775/JEHS.2023.13.04.014
[10] Puchalska, P., & Crawford, P. A. (2017). Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell metabolism, 25(2), 262–284. https://doi.org/10.1016/j.cmet.2016.12.022
[11] Kayode, T. O., Rotimi, E. D., Afolayan, A. O., & Kayode, A. A. A. (2020). Ketogenic diet: A nutritional remedy for some metabolic disorders. Journal of Education, Health and Sport, 10(8), 180–188. https://doi.org/10.12775/JEHS.2020.10.08.021
[12] Rubio, C., López-Landa, A., Romo-Parra, H., & Rubio-Osornio, M. (2025). Impact of the Ketogenic Diet on Neurological Diseases: A Review. Life (Basel, Switzerland), 15(1), 71. https://doi.org/10.3390/life15010071
[13] Morris A. A. (2005). Cerebral ketone body metabolism. Journal of inherited metabolic disease, 28(2), 109–121. https://doi.org/10.1007/s10545-005-5518-0
[14] Halestrap A. P. (2013). The SLC16 gene family - structure, role and regulation in health and disease. Molecular aspects of medicine, 34(2-3), 337–349. https://doi.org/10.1016/j.mam.2012.05.003
[15] Bough, K. J., & Rho, J. M. (2007). Anticonvulsant mechanisms of the ketogenic diet. Epilepsia, 48(1), 43–58. https://doi.org/10.1111/j.1528-1167.2007.00915.x
[16] Cunnane, S. C., Courchesne-Loyer, A., Vandenberghe, C., St-Pierre, V., Fortier, M., Hennebelle, M., Croteau, E., Bocti, C., Fulop, T., & Castellano, C. A. (2016). Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease. Frontiers in molecular neuroscience, 9, 53. https://doi.org/10.3389/fnmol.2016.00053
[17] Gasior, M., Rogawski, M. A., & Hartman, A. L. (2006). Neuroprotective and disease-modifying effects of the ketogenic diet. Behavioural pharmacology, 17(5-6), 431–439. https://doi.org/10.1097/00008877-200609000-00009
[18] Maalouf, M., Rho, J. M., & Mattson, M. P. (2009). The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain research reviews, 59(2), 293–315. https://doi.org/10.1016/j.brainresrev.2008.09.002
[19] Youm, Y. H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., Kang, S., Horvath, T. L., Fahmy, T. M., Crawford, P. A., Biragyn, A., Alnemri, E., & Dixit, V. D. (2015). The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature medicine, 21(3), 263–269. https://doi.org/10.1038/nm.3804
[20] Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., Newgard, C. B., Farese, R. V., Jr, de Cabo, R., Ulrich, S., Akassoglou, K., & Verdin, E. (2013). Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science (New York, N.Y.), 339(6116), 211–214. https://doi.org/10.1126/science.1227166
[21] Xie, Z., Zhang, D., Chung, D., Tang, Z., Huang, H., Dai, L., Qi, S., Li, J., Colak, G., Chen, Y., Xia, C., Peng, C., Ruan, H., Kirkey, M., Wang, D., Jensen, L. M., Kwon, O. K., Lee, S., Pletcher, S. D., Tan, M., … Zhao, Y. (2016). Metabolic Regulation of Gene Expression by Histone Lysine β-Hydroxybutyrylation. Molecular cell, 62(2), 194–206. https://doi.org/10.1016/j.molcel.2016.03.036
[22] Sleiman, S. F., Henry, J., Al-Haddad, R., El Hayek, L., Abou Haidar, E., Stringer, T., Ulja, D., Karuppagounder, S. S., Holson, E. B., Ratan, R. R., Ninan, I., & Chao, M. V. (2016). Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate. eLife, 5, e15092. https://doi.org/10.7554/eLife.15092
[23] Yoshii, A., & Constantine-Paton, M. (2010). Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Developmental neurobiology, 70(5), 304–322. https://doi.org/10.1002/dneu.20765
[24] Henderson S. T. (2008). Ketone bodies as a therapeutic for Alzheimer's disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 5(3), 470–480. https://doi.org/10.1016/j.nurt.2008.05.004
[25] Krikorian, R., Shidler, M. D., Dangelo, K., Couch, S. C., Benoit, S. C., & Clegg, D. J. (2012). Dietary ketosis enhances memory in mild cognitive impairment. Neurobiology of aging, 33(2), 425.e19–425.e4.25E27. https://doi.org/10.1016/j.neurobiolaging.2010.10.006
[26] Taylor, M. K., Sullivan, D. K., Mahnken, J. D., Burns, J. M., & Swerdlow, R. H. (2017). Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.), 4, 28–36. https://doi.org/10.1016/j.trci.2017.11.002
[27] Phillips, M. C. L., Murtagh, D. K. J., Gilbertson, L. J., Asztely, F. J. S., & Lynch, C. D. P. (2018). Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial. Movement disorders : official journal of the Movement Disorder Society, 33(8), 1306–1314. https://doi.org/10.1002/mds.27390
[28] Rog, J., Wingralek, Z., Nowak, K., Grudzień, M., Grunwald, A., Banaszek, A., & Karakula-Juchnowicz, H. (2024). The Potential Role of the Ketogenic Diet in Serious Mental Illness: Current Evidence, Safety, and Practical Advice. Journal of clinical medicine, 13(10), 2819. https://doi.org/10.3390/jcm13102819
[29] Campbell, I. H., & Campbell, H. (2019). Ketosis and bipolar disorder: controlled analytic study of online reports. BJPsych open, 5(4), e58. https://doi.org/10.1192/bjo.2019.49
[30] Włodarczyk, A., Cubała, W. J., & Stawicki, M. (2021). Ketogenic diet for depression: A potential dietary regimen to maintain euthymia?. Progress in neuro-psychopharmacology & biological psychiatry, 109, 110257. https://doi.org/10.1016/j.pnpbp.2021.110257
[31] Phelps, J. R., Siemers, S. V., & El-Mallakh, R. S. (2013). The ketogenic diet for type II bipolar disorder. Neurocase, 19(5), 423–426. https://doi.org/10.1080/13554794.2012.690421
[32] Danan, A., Westman, E. C., Saslow, L. R., & Ede, G. (2022). The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients. Frontiers in psychiatry, 13, 951376. https://doi.org/10.3389/fpsyt.2022.951376
[33] Sarnyai, Z., Kraeuter, A. K., & Palmer, C. M. (2019). Ketogenic diet for schizophrenia: clinical implication. Current opinion in psychiatry, 32(5), 394–401. https://doi.org/10.1097/YCO.0000000000000535
[34] Palmer, C. M., Gilbert-Jaramillo, J., Westman, E. C. (2019). The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case reports. Schizophrenia Research, 208, 439-440. https://doi.org/10.1016/j.schres.2019.03.019
[35] Kraeuter, A. K., Loxton, H., Lima, B. C., Rudd, D., & Sarnyai, Z. (2015). Ketogenic diet reverses behavioral abnormalities in an acute NMDA receptor hypofunction model of schizophrenia. Schizophrenia research, 169(1-3), 491–493. https://doi.org/10.1016/j.schres.2015.10.041
[36] Kraft, B. D., Westman, E. C. (2009). Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. Nutrition & Metabolism, 6, 10. https://doi.org/10.1186/1743-7075-6-10
[37] Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018). The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet. Cell, 173(7), 1728–1741.e13. https://doi.org/10.1016/j.cell.2018.04.027
[38] Gao, M., Kirk, M., Knight, H., Lash, E., Michalopoulou, M., Guess, N., Stevens, R., Browning, M., Weich, S., Burnet, P. W. J., Jebb, S. A., & Aveyard, P. (2026). A Ketogenic Diet for Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA psychiatry, 83(4), 331–340. https://doi.org/10.1001/jamapsychiatry.2025.4431
[39] Kuźniar, J., Kozubek, P., Czaja, M., Sitka, H., & Wegenko, C. (2024). Ketogenic diet and intermittent fasting - impact on body weight and various diseases. Journal of Education, Health and Sport, 70, 55560. https://doi.org/10.12775/JEHS.2024.70.55560
[40] Bartosik, K., Furtek, D., Ostrowicz, K., & Kurenda, K. (2025). The Impact of the Ketogenic Diet on Athletic Performance: A Systematic Literature Review. Quality in Sport, 43, 62344. https://doi.org/10.12775/QS.2025.43.62344
[41] Harvey, C. J. D. C., Schofield, G. M., & Williden, M. (2018). The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review. PeerJ, 6, e4488. https://doi.org/10.7717/peerj.4488
[42] Gjuladin-Hellon, T., Davies, I. G., Penson, P., & Amiri Baghbadorani, R. (2019). Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis. Nutrition reviews, 77(3), 161–180. https://doi.org/10.1093/nutrit/nuy049
[43] Pérez-Guisado, J., Muñoz-Serrano, A., & Alonso-Moraga, A. (2008). Spanish Ketogenic Mediterranean Diet: a healthy cardiovascular diet for weight loss. Nutrition journal, 7, 30. https://doi.org/10.1186/1475-2891-7-30
[44] Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013). Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. European journal of clinical nutrition, 67(8), 789–796. https://doi.org/10.1038/ejcn.2013.116
[45] Muscogiuri, G., Barrea, L., Laudisio, D., Pugliese, G., Salzano, C., Savastano, S., & Colao, A. (2019). The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide. Journal of translational medicine, 17(1), 356. https://doi.org/10.1186/s12967-019-2104-z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Arkadiusz Psiuk, Joanna Szymocha, Igor Smędowski, Jarosław Tsukerman, Aleksandra Wojas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 136
Number of citations: 0
